OPEN ACCESS | PEER-REVIEWED | RESEARCH ARTICLE | DOWNLOAD PDF | VIEW FULL-TEXT PDF | TOTAL VIEWS
Theoretical investigation of a few selected compounds as potent anti-tubercular agents and molecular docking evaluation: A multi-linear regression approach
Shola Elijah Adeniji (1,*) , Abdulwahab Isiaka (2) , Kalen Ephraim Audu (3) , Olajumoke Bosede Adalumo (4)
(1) Department of Chemistry, Ahmadu Bello University, Zaria, Kaduna State 810107, Nigeria
(2) Department of Chemistry, Ahmadu Bello University, Zaria, Kaduna State 810107, Nigeria
(3) Department of Biology, Ahmadu Bello University, Zaria, Kaduna State 810107, Nigeria
(4) Department of Science Education, Ajasin University, Akungba Akoko, Ondo State 342211, Nigeria
(*) Corresponding Author
Received: 17 Dec 2019 | Revised: 05 Feb 2020 | Accepted: 07 Feb 2020 | Published: 31 Mar 2020 | Issue Date: March 2020
Emergence of multi-drug resistant strains of Mycobacterium tuberculosis to the available drugs has demanded for the development of more potent anti-tubercular agents with efficient pharmacological activities. Time consumed and expenses in discovering and synthesizing new drug targets with improved biological activity have been a major challenge toward the treatment of multi-drug resistance strain M. tuberculosis. To solve the above problem, Quantitative Structure Activity Relationship (QSAR) is a recent approach developed to discover a novel drug with a better biological against M. Tuberculosis. A validated QSAR model developed in this study to predict the biological activities of some anti-tubercular compounds and to design new hypothetical drugs is influenced with the molecular descriptors; AATS7s, VR1-Dzi, VR1-Dzs, SpMin7-Bhe and RDF110i. The internal validation test for the derived model was found to have correlation coefficient (R2) of 0.8875, adjusted correlation coefficient (R2adj) value of 0.8234 and leave one out cross validation coefficient (Qcv2) value of 0.8012 while the external validation test was found to have (R2test) of 0.7961 and Y-randomization Coefficient (cRp2) of 0.6832. Molecular docking shows that ligand 13 of 2,4-disubstituted quinoline derivatives have promising higher binding score of -18.8 kcal/mol compared to the recommended drugs; isoniazid -14.6 kcal/mol. The proposed QSAR model and molecular docking studies will provides valuable approach for the modification of the lead compound, designing and synthesis more potent anti-tubercular agents.
Links for Article
| | | | | | |
| | | | | | |
| | |
Article MetricsThis Abstract was viewed 1147 times | PDF Article downloaded 143 times
Cited byCrossref database responds too late...
. World Health Organization, Tuberculosis, Retrieved Feb 01, 2020, from http://www.who.int/news-room/fact-sheets/detail/ tuberculosis.
. Hansch, C.; Kurup, A.; Garg, R.; Gao, H. Chem. Rev. 2001, 101, 619-672.
. Adeniji, S. E.; Uba, S.; Uzairu, A. J. Pathog. 2018, 1018694.
. Ogadimma, A. I.; Adamu, U. Open Access Lib. J. 2016, 3, 1-13.
. Eric, G. M.; Uzairu, A.; Mamza, P. A. J. Sci. Res. Rep. 2016, 10, 1-15.
. Adeniji, S. E.; Uba, S.; Uzairu, A. Phys. Chem. Res. 2018, 6, 479-492.
. Adeniji, S. E.; Uba, S.; Uzairu, A. J. King Saud University-Sci. 2020, 32(1), 67-74.
. Nayyar, A.; Jain, R. Indian J. Chem. B 2008, 47, 117-128.
. Yap, C. W. J. Comput. Chem. 2011, 32, 1466-1474.
. Singh, P. J. Curr. Chem. Pharm. Sci. 2013, 3(1), 64-79.
. Adeniji, S. E.; Uba, S.; Uzairu, A.; Arthur, D. E. Adv. Preventive Med. 2019, 5173786, 1-18.
. Tropsha, A.; Gramatica, P.; Gombar, V. K. Mol. Inform. 2003, 22, 69-77.
. Roy, K.; Chakraborty, P.; Mitra, I.; Ojha, P. K.; Kar, S.; Das, R. N. J. Comput. Chem. 2013, 34, 1071-1082.
. Veerasamy, R.; Rajak, H.; Jain, A.; Sivadasan, S.; Varghese, C. P.; Agrawal, R. K. Int. J. Drug Des. Discover. 2011, 2(3), 511-519.
. Adeniji, S. E.; Uba, S.; Uzairu, A. Netw. Model. Anal. Health Inform. Bioinforma. 2020, 9(8), 1-18.
. Piton, J.; Petrella, S.; Delarue, M.; Andre-Leroux, G.; Jarlier, V.; Aubry, A.; Mayer, C. Retrieved Feb 01, 2020, from https://www. rcsb. org/structure/3IFZ
. Adeniji, S. E.; Uba, S.; Uzairu, A. Future. J. Pharm. Sci. 2018, 4, 284-295.
How to cite
The other citation formats (EndNote | Reference Manager | ProCite | BibTeX | RefWorks) for this article can be found online at: How to cite item
DOI Link: https://doi.org/10.5155/eurjchem.11.1.60-67.1949
| | | | | | | | |
| | | | | |
Save to Zotero Save to Mendeley
European Journal of Chemistry 2020, 11(1), 60-67 | doi: https://doi.org/10.5155/eurjchem.11.1.60-67.1949 | Get rights and content
- There are currently no refbacks.
Copyright (c) 2020 Authors
This work is published and licensed by Atlanta Publishing House LLC, Atlanta, GA, USA. The full terms of this license are available at http://www.eurjchem.com/index.php/eurjchem/pages/view/terms and incorporate the Creative Commons Attribution-Non Commercial (CC BY NC) (International, v4.0) License (http://creativecommons.org/licenses/by-nc/4.0). By accessing the work, you hereby accept the Terms. This is an open access article distributed under the terms and conditions of the CC BY NC License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited without any further permission from Atlanta Publishing House LLC (European Journal of Chemistry). No use, distribution or reproduction is permitted which does not comply with these terms. Permissions for commercial use of this work beyond the scope of the License (http://www.eurjchem.com/index.php/eurjchem/pages/view/terms) are administered by Atlanta Publishing House LLC (European Journal of Chemistry).
© Copyright 2010 - 2021 • Atlanta Publishing House LLC • All Right Reserved.
The opinions expressed in all articles published in European Journal of Chemistry are those of the specific author(s), and do not necessarily reflect the views of Atlanta Publishing House LLC, or European Journal of Chemistry, or any of its employees.
Copyright 2010-2021 Atlanta Publishing House LLC. All rights reserved. This site is owned and operated by Atlanta Publishing House LLC whose registered office is 2850 Smith Ridge Trce Peachtree Cor GA 30071-2636, USA. Registered in USA.